Lincoln Pharmaceuticals Limited (LINCOLN.NS)
INR 552.6
(3.05%)
INR 552.6
(3.05%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 46.58 INR | 27.97% |
| 2022 | 36.40 INR | 5.11% |
| 2021 | 34.63 INR | 11.42% |
| 2020 | 31.08 INR | 20.84% |
| 2019 | 25.72 INR | 5.58% |
| 2018 | 24.36 INR | 40.73% |
| 2017 | 17.31 INR | 10.04% |
| 2016 | 15.73 INR | 8.33% |
| 2015 | 14.52 INR | 57.83% |
| 2014 | 9.20 INR | 40.89% |
| 2013 | 6.53 INR | 10.3% |
| 2012 | 5.92 INR | 88.54% |
| 2011 | 3.14 INR | 3.97% |
| 2010 | 3.02 INR | -54.99% |
| 2009 | 6.71 INR | 17.31% |
| 2008 | 5.72 INR | -6.69% |
| 2007 | 6.13 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 11.82 INR | 27.37% |
| 2023 Q4 | 9.28 INR | -33.71% |
| 2023 FY | - INR | 27.97% |
| 2023 Q1 | 9.49 INR | 51.36% |
| 2023 Q2 | 13.81 INR | 45.52% |
| 2023 Q3 | 14.00 INR | 1.38% |
| 2022 Q2 | 11.84 INR | 57.66% |
| 2022 Q3 | 10.79 INR | -8.87% |
| 2022 Q4 | 6.27 INR | -41.89% |
| 2022 Q1 | 7.51 INR | 36.3% |
| 2022 FY | - INR | 5.11% |
| 2021 Q4 | 5.51 INR | -37.32% |
| 2021 FY | - INR | 11.42% |
| 2021 Q1 | 8.84 INR | 40.54% |
| 2021 Q2 | 11.50 INR | 30.09% |
| 2021 Q3 | 8.79 INR | -23.57% |
| 2020 Q3 | 6.73 INR | -35.66% |
| 2020 Q2 | 10.46 INR | 37.09% |
| 2020 Q1 | 7.63 INR | 70.69% |
| 2020 Q4 | 6.29 INR | -6.54% |
| 2020 FY | - INR | 20.84% |
| 2019 Q3 | 5.46 INR | -42.28% |
| 2019 Q4 | 4.47 INR | -18.13% |
| 2019 FY | - INR | 5.58% |
| 2019 Q1 | 6.33 INR | 48.94% |
| 2019 Q2 | 9.46 INR | 49.45% |
| 2018 Q1 | 8.03 INR | 135.48% |
| 2018 Q4 | 4.25 INR | -7.0% |
| 2018 Q2 | 7.50 INR | -6.6% |
| 2018 Q3 | 4.57 INR | -39.07% |
| 2018 FY | - INR | 40.73% |
| 2017 Q3 | 5.79 INR | 2.48% |
| 2017 FY | - INR | 10.04% |
| 2017 Q4 | 3.41 INR | -41.11% |
| 2017 Q2 | 5.65 INR | 129.67% |
| 2017 Q1 | 2.46 INR | 272.73% |
| 2016 FY | - INR | 8.33% |
| 2016 Q3 | 3.27 INR | -39.67% |
| 2016 Q2 | 5.42 INR | -22.46% |
| 2016 Q1 | 6.99 INR | 184.15% |
| 2016 Q4 | 0.66 INR | -79.82% |
| 2015 Q3 | 3.88 INR | -5.37% |
| 2015 Q1 | 4.01 INR | 264.55% |
| 2015 FY | - INR | 57.83% |
| 2015 Q2 | 4.10 INR | 2.24% |
| 2015 Q4 | 2.46 INR | -36.6% |
| 2014 Q2 | 4.29 INR | 116.67% |
| 2014 Q4 | 1.10 INR | -30.82% |
| 2014 Q3 | 1.59 INR | -62.94% |
| 2014 Q1 | 1.98 INR | 465.71% |
| 2014 FY | - INR | 40.89% |
| 2013 Q3 | 2.02 INR | -3.35% |
| 2013 Q1 | 1.99 INR | -2.93% |
| 2013 Q2 | 2.09 INR | 5.03% |
| 2013 Q4 | 0.35 INR | -82.67% |
| 2013 FY | - INR | 10.3% |
| 2012 Q4 | 2.05 INR | 122.83% |
| 2012 Q3 | 0.92 INR | -54.0% |
| 2012 Q2 | 2.00 INR | 300.0% |
| 2012 Q1 | 0.50 INR | 31.58% |
| 2012 FY | - INR | 88.54% |
| 2011 Q3 | 0.32 INR | 0.0% |
| 2011 FY | - INR | 3.97% |
| 2011 Q4 | 0.38 INR | 18.75% |
| 2010 FY | - INR | -54.99% |
| 2009 FY | - INR | 17.31% |
| 2008 FY | - INR | -6.69% |
| 2008 Q4 | -0.50 INR | 0.0% |
| 2007 FY | - INR | 0.0% |
| 2007 Q4 | 0.11 INR | 0.0% |